KRW172,600.00
0.98% today
Korea, Aug 26, 08:08 am CET
ISIN
KR7068270008
Symbol
068270
Index

Celltrion Stock price

KRW172,900.00
-4,600.00 2.59% 1M
-9,119.23 5.01% 6M
-7,388.47 4.10% YTD
-14,026.07 7.50% 1Y
+7,572.96 4.58% 3Y
-86,513.93 33.35% 5Y
+122,267.59 241.48% 10Y
+169,835.21 5,541.50% 20Y
Korea, Closing price Tue, Aug 26 2025
-1,400.00 0.80%
ISIN
KR7068270008
Symbol
068270
Index
Industry

Key metrics

Basic
Market capitalization
KRW38.2t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
78.4 | 45.0
P/S
10.2 | 8.9
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
KRW721.15
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
57.5% | -
Payout 1Y | 3Y
21.0% | 14.1%
Increased
2 Years
Financials (TTM | estimate)
Revenue
KRW3.7t | KRW4.3t
EBITDA
KRW863.0b | KRW1.6t
EBIT
KRW796.0b | KRW1.2t
Net Income
KRW492.1b | -
Free Cash Flow
KRW559.3b
Growth (TTM | estimate)
Revenue
40.6% | 20.9%
EBITDA
63.3% | 136.8%
EBIT
115.4% | 147.8%
Net Income
52.2% | -
Free Cash Flow
582.7%
Margin (TTM | estimate)
Gross
53.2%
EBITDA
23.0% | 37.0%
EBIT
21.2%
Net
13.1% | -
Free Cash Flow
14.9%
Financial Health
Equity Ratio
82.8%
Return on Equity
2.4%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
KRW2,224.5
FCF per Share
-
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Celltrion forecast:

25x Buy
86%
3x Hold
10%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Celltrion forecast:

Buy
86%
Hold
10%
Sell
3%

Financial data from Celltrion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
3,748,951 3,748,951
41% 41%
100%
- Direct Costs 1,754,511 1,754,511
19% 19%
47%
1,994,440 1,994,440
68% 68%
53%
- Selling and Administrative Expenses 914,682 914,682
40% 40%
24%
- Research and Development Expense 216,763 216,763
-
6%
862,995 862,995
63% 63%
23%
- Depreciation and Amortization 67,017 67,017
58% 58%
2%
EBIT (Operating Income) EBIT 795,978 795,978
115% 115%
21%
Net Profit 492,078 492,078
52% 52%
13%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Wu-Sung Ki
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today